Bio

Dr. McGuirk completed his residency at Yale, fellowship at Memorial Sloan Kettering Cancer Center and subsequently served as Associate Director of the Yale Stem Cell Transplant Program. He currently serves as Director for the Division of Hematologic Malignancies and Cellular Therapeutics at the University of Kansas Cancer Center and holds the endowed Schutte-Speas Professorship in Hematology-Oncology. Dr. McGuirk currently serves in ASTCT Board of Directors as a Director, and Chairs the AACI National CAR-T initiative. He has worked in the field of hematologic malignancies for over 29 years and has published extensively in the areas of stem cell transplantation and cellular therapeutics. Additionally, Dr. McGuirk serves as the principal investigator of numerous clinical trials in both areas, and currently oversees many cellular therapy clinical trials, including two investigator-initiated trials for which he holds an FDA IND.